Aaron Mann is the CEO of Kindeva Drug Delivery, a private company spun off from 3M in 2020 and backed by Altaris Capital Partners and 3M.
At 3M, Aaron led the Drug Delivery Systems business and held responsibility for strategy and business development for the Health Care Business Group.
Prior to 3M, he ran corporate development, strategy and marketing at Phillips-Medisize, a global contract designer and manufacturer of drug delivery and medical device products, and led Operations at Remedi Senior Care, an institutional pharmacy. Aaron began his career at Bain & Company.
Aaron holds a BA in Economics from Carleton College and an MBA from the Harvard Business School.